Foghorn Therapeutics is a clinical-stage biotechnology company focused on developing precision medicines that target the chromatin regulatory system to treat serious diseases, primarily in oncology. The company serves patients with cancers and other diseases where chromatin regulation is disrupted.
Description via Wikipedia
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.